<DOC>
	<DOCNO>NCT00055718</DOCNO>
	<brief_summary>RATIONALE : Silymarin ( milk thistle extract ) herb may effective treat liver disorder cause cancer therapy . PURPOSE : Randomized phase II trial study effectiveness silymarin treat patient acute lymphoblastic leukemia chemotherapy-related side effect liver .</brief_summary>
	<brief_title>Silymarin ( Milk Thistle Extract ) Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy</brief_title>
	<detailed_description>OBJECTIVES : - Determine effect silymarin , term liver function test , patient acute lymphoblastic leukemia receive hepatotoxic chemotherapy . - Determine effect drug free conjugate serum silibinin value patient . - Determine serum antioxidant capacity Oxygen Radical Absorbance Capacity patient treat drug . - Determine oxidative damage , determine 8-oxodeoxyguanosine adduct , patient treat drug . OUTLINE : This randomize , double-blind , placebo-controlled study . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral silymarin daily 28 day . - Arm II : Patients receive oral placebo arm I . Patients follow day 56 . PROJECTED ACCRUAL : A total 50 patient ( 25 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Silymarin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute lymphoblastic leukemia ( ALL ) Currently receive maintenance continuation phase chemotherapy ALL Regimen comprise intrathecal oral methotrexate ; vincristine IV ; oral prednisone dexamethasone ; oral mercaptopurine Elevated liver function test , evidence 1 follow criterion : Bilirubin great 1.5 time upper limit normal ( ULN ) AST great 2.5 time ULN ALT great 2.5 time ULN PATIENT CHARACTERISTICS : Age 2 21 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic See Disease Characteristics Renal Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics Endocrine therapy See Disease Characteristics Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>drug/agent toxicity tissue/organ</keyword>
	<keyword>childhood acute lymphoblastic leukemia</keyword>
</DOC>